Partner Content Partner Content Amgen on the role of RWE in a Product Evidence Generation Pl... Amgen on key challenges that can be addressed with RWE
Partner Content Partner Content Department for International Trade to present at Wearable In... Wearable Injectors and Connected Devices Conference
Partner Content Partner Content AstraZeneca to lead a workshop during the Wearable Injectors... Wearable Injectors and Connected Devices Conference
Partner Content Partner Content Registration is now open for the inaugural Wearable Injector... Registration open for the inaugural Wearable Injectors
Partner Content Partner Content Dr. Delma L Broussard to Speak at PFS West Coast Conference Dr. Delma L Broussard to Speak at Prefilled Syringes WC
Events Partner Content 3rd Annual Bay Area Pharma Market Research Conference The largest assembly of market research experts
News Lilly bags FDA okay for Wegovy pill rival orforglipron Eli Lilly has claimed US approval for oral GLP-1 agonist orforglipron, setting up a market clash with Novo Nordisk's first-to-market Wegovy pill.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
